Peng Ge, Pan Xiaohui, Ye Ziwei, Yi Xianyanling, Xie Qingxing, Zhang Xinyi, Tong Nanwei
Division of Endocrinology and Metabolism, Laboratory of Diabetes and Metabolism Research, West China Hospital, Sichuan University, Chengdu, China.
Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Endocrine. 2025 Apr;88(1):60-74. doi: 10.1007/s12020-024-04155-x. Epub 2025 Jan 2.
The incidence of thyroid cancer has increased annually, but the risk factors for thyroid cancer are still unclear. In this umbrella review, we aimed to identify associations between nongenetic risk factors and thyroid cancer incidence, and assess the quality and validity of the evidence.
PubMed, Embase and the Cochrane Database of Systematic Reviews were searched to identify related meta-analyses or systematic reviews of epidemiological studies. We extracted the estimated summary effect and 95% confidence interval (CI) through fixed or random effects models of each meta-analysis. AMSTAR2 and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) were used to evaluate the methodological quality of the included meta-analyses and the quality of evidence respectively. Further subgroup analyses by sex and sensitivity analyses were conducted.
We identified 53 articles with 112 associations, of which 69 had significant relationships with thyroid cancer risk, including factors related to iodine, nitrates, fish, vitamin D, tea, alcohol, smoke, body mass index (BMI), pesticides, X-ray, I, oral contraceptives, flavonoids, reproductive factors and some medical conditions. However, most studies (65%) were categorized as "critically low" on the basis of AMSTAR2, and most evidence (86%) was of weak quality since the classification by GRADE was very low. Moreover, subgroup and sensitivity analyses revealed more risk factors in women than in men.
We found that several modifiable factors have essential effects in the primary prevention of thyroid cancer, but few high-quality studies exist. In the future, more well-conducted, especially prospective, studies are needed to confirm the results.
The protocol for this review was registered in PROSPERO (CRD42022352841).
甲状腺癌的发病率逐年上升,但甲状腺癌的危险因素仍不清楚。在这项伞状综述中,我们旨在确定非遗传危险因素与甲状腺癌发病率之间的关联,并评估证据的质量和有效性。
检索了PubMed、Embase和Cochrane系统评价数据库,以确定相关的荟萃分析或流行病学研究的系统评价。我们通过每个荟萃分析的固定效应或随机效应模型提取估计的汇总效应和95%置信区间(CI)。分别使用AMSTAR2和推荐分级、评估、制定与评价(GRADE)来评估纳入的荟萃分析的方法学质量和证据质量。进行了按性别进一步的亚组分析和敏感性分析。
我们确定了53篇文章,包含112个关联,其中69个与甲状腺癌风险有显著关系,包括与碘、硝酸盐、鱼类、维生素D、茶、酒精、吸烟、体重指数(BMI)、农药、X射线、I、口服避孕药、类黄酮、生殖因素和一些医疗状况相关的因素。然而,根据AMSTAR2,大多数研究(65%)被归类为“极低”,并且由于GRADE分类非常低,大多数证据(86%)质量较弱。此外,亚组和敏感性分析显示,女性的危险因素比男性更多。
我们发现一些可改变的因素在甲状腺癌的一级预防中具有重要作用,但高质量的研究很少。未来,需要更多设计良好的研究,尤其是前瞻性研究,以证实这些结果。
本综述的方案已在PROSPERO(CRD42022352841)中注册。